Topics

"Hall Joins AccessOne Senior Vice President Business Development∨derfield=date∨derval=DESC" News Stories

23:52 EDT 18th July 2019 | BioPortfolio

Here are the most relevant search results for "Hall Joins AccessOne Senior Vice President Business Development∨derfield=date∨derval=DESC" found in our extensive news archives from over 250 global news sources.

More Information about Hall Joins AccessOne Senior Vice President Business Development∨derfield=date∨derval=DESC on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Hall Joins AccessOne Senior Vice President Business Development∨derfield=date∨derval=DESC for you to read. Along with our medical data and news we also list Hall Joins AccessOne Senior Vice President Business Development∨derfield=date∨derval=DESC Clinical Trials, which are updated daily. BioPortfolio also has a large database of Hall Joins AccessOne Senior Vice President Business Development∨derfield=date∨derval=DESC Companies for you to search.

Showing "Hall Joins AccessOne Senior Vice President Business Development" News Articles 1–25 of 28,000+

Thursday 18th July 2019

Malaysian Mountain Climbing Icon Ravi Everest Joins 9th Annual Expedition Mt. Kinabalu to Raise Awareness for Duchenne Muscular Dystrophy

Organizers highlight ongoing Duchenne research at Kuala Lumpur Hospital and University Malaya Medical Centre NEWPORT BEACH, Calif. (PRWEB) July 18, 2019 World renowned two-time Everest summiter Ravichandran Tharumalingam, who is also known as “Ravi Everest,” will be joining forces with California-based charity Coalition Duchenne for its 9th Annual Expedition Mt. Kinabalu in Sabah, Malaysia, t...


[Articles] The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults

Our study provides important evidence for the design and targeting of health policies and service interventions for hypertension in LMICs. We show at what steps and for whom there are gaps in the hypertension care process in each of the 44 countries in our study. We also identified countries in each world region that perform better than expected from their economic development, which can direct po...

Opinion: Waste and inefficiency in drug development are big problems. They can be hard to spot, especially when you are in the midst of the process. A new way of visualizing clinical trials might help. https://buff.ly/2GiYy7X 

Opinion: Waste and inefficiency in drug development are big problems. They can be hard to spot, especially when you are in the midst of the process. A new way of visualizing clinical trials might help. https://buff.ly/2GiYy7X 


Anorexia redefined as both metabolic and psychiatric

A large-scale genome-wide association study, led by researchers at King’s College London and the University of North Carolina at Chapel Hill (UNC), suggests that anorexia nervosa is at least partly a metabolic disorder, and not purely psychiatric as previously thought. The groundbreaking results of the study have been published in the journal Nature Genetics. Anorexia nervosa is a serious and p...

Agilent expands cell analysis portfolio with BioTek acquisition

Agilent Technologies has signed a definitive agreement to acquire the privately owned BioTek Instruments for $1.165 billion. With anticipated tax benefits for Agilent, the net purchase price is expected to be approximately $1.05 billion. Headquartered in Vermont, USA, BioTek is a designer, manufacturer and distributor of innovative life science instrumentation. Its comprehensive product line incl...

Medicxi Closes a New €400m Fund (Medicxi III) to Power the Next Wave of Biopharma Entrepreneurs and Drug Hunters

€400m Medicxi III fund, closed in just six weeks, and brings the total funds raised by Medicxi in the last three years to over $1b Medicxi III will invest across the full healthcare continuum, from discovery to late stage clinical assets, empowering ambitious scientific entrepreneurs and drug hunters Novartis and Johnson & Johnson Innovation – JJDC, Inc. are returning cornerstone inv...

IRS Notice, Newly Introduced Medicare Legislation Work to Expand Benefits of Health Savings Accounts for Millions of Americans

HealthEquity helps introduce legislation that would allow Medicare recipients to open and contribute to HSAs; IRS expands preventive care benefit options for chronic conditions HealthEquity, Inc. (NASDAQ: HQY), the nation’s largest independent health savings account (HSA) non-bank custodian, participated in drafting legislation announced today that along with a new IRS notice, will expand the...

Sensient Technologies Corporation Elects Carol Jackson to its Board of Directors

Sensient Technologies today announced the election of Carol Jackson to its Board of Directors, effective December 1, 2019. Ms. Jackson is Chairman, President, and Chief Executive Officer of Harbison Walker International, the largest supplier of ceramic refractories in the U.S. with operations in the U.S., Mexico, Europe, and Southeast Asia and commercial interests globally. The 150-year-old com...

Flex Pharma Announces Rights Dividend

Flex Pharma, Inc. (Nasdaq: FLKS) announced that its Board of Directors today declared a special dividend on the Company’s common stock of one right per share of outstanding common stock. The rights will be paid on July 19, 2019 to shareholders of record as of close of business on July 18, 2019. Flex Pharma has not listed, and does not intend to list, the rights for trading on any exchange. Th...

Regenerage International, IIMET, and Bioquark Inc. to Collaborate on Clinical Study in Biologic Age Reversal of Photodamaged Skin

Regenerage, IIMET, and Bioquark, Inc. are undertaking a 12-week clinical trial, of a novel topical formulation, to study biologic reversal of aging in photodamaged skin. CHICAGO, PHILADELPHIA, an ZAPOPAN, Mexico (PRWEB) July 18, 2019 Regenerage International Inc., a clinical company focused on therapeutic and consumer applications of regenerative healthcare; IIMET, a Mexico based contract researc...

ImmunoGen Announces Conference Call to Discuss Its Second Quarter 2019 Operating Results

ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, August 2, 2019 to discuss its second quarter operating results. Management will also provide a brief update on the business. CONFERENCE CALL INFORMATION To access the live call ...

Henry Schein, Inc. Awards Fourth Annual Henry Schein Cares Medals in the Medical Category; Names LifeNet International ‘Best in Class’

Medal Recognizes Organizations That Reflect Company’s Commitment to Expanding Access to Care for People in Need Henry Schein, Inc. (Nasdaq: HSIC) today announced that it has awarded its fourth annual Henry Schein Cares Medals in the Medical category, recognizing three nonprofit organizations and naming Orlando, Florida-based LifeNet International (LN) as “Best In Class.” The Henry Schein C...

Manhattan Scientifics Announces Breakthrough Device for Detection of Cancer

Manhattan Scientifics Inc.’s (OTC: QB MHTX) former wholly-owned subsidiary that was initially funded by MHTX, Imagion Biosystems Ltd (ASX:IBX) over a nine-year period has received confirmation from the Food and Drug Administration (FDA) that the MagSense System and Test for staging

Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics

INGELHEIM, Germany & SEONGNAM, Korea–(BUSINESS WIRE)–Boehringer Ingelheim and Bridge Biotherapeutics Inc. today announced that they are entering into a new collaboration and license agreement with the goal of developing Bridge Biotherapeutics’s autotaxin inhibitor BBT-877 for patients with fibrosing interstitial lung diseases, including IPF. BBT-877 is currently in Phase I clin...

Chembio Diagnostics and Takeda Pharmaceutical Company Collaborate for Development of Point-of-Care Diagnostic Test

MEDFORD, N.Y., July 18, 2019 (GLOBE NEWSWIRE) — Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care (POC) diagnostics company focused on infectious diseases, today announced that it has entered into a collaboration with Shire Human Genetic Therapies, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, a global pharmaceutical company, to develop a novel ...

Medicxi Closes €400m Medicixi III Biotech Fund In 6 Weeks

European life sciences investment firm Medicxi shows institutional investor appetite for life sciences venture capital is still strong as it...    

LC GC® Presents Webcast on Automated Volatiles Analysis

The live broadcast will feature insight from key industry leaders LC GC®, a leading multimedia platform of peer-reviewed technical information on the field of chromatography and the separation sciences, will host the webcast “High-Throughput, Automated Volatiles Analysis From Air, Headspace and Thermal Desorption Tubes” on Tuesday, July 23, at 11 a.m. EDT. “Conventional laboratory analy...

Avante Health Solutions Names Craig Rothman Director of Health Systems

Rothman will work with key Avante personnel to develop and execute the company’s GPO contracting strategy. CHICAGO (PRWEB) July 18, 2019 Avante Health Solutions is pleased to welcome Craig Rothman as the company’s Director of Health Systems. Rothman joins the Avante team with more than 25 years of healthcare products and services experience, with the last 16 years spent specifically working w...

LifeMax Receives Rare Pediatric Disease Designation from the FDA for LM-030 for the Treatment of Netherton Syndrome

PALO ALTO, Calif.–(BUSINESS WIRE)–LifeMax Laboratories, Inc. (“LifeMax”), a private company focused on treating rare diseases with few or no therapeutic options, today announced that the Food & Drug Administration (FDA) granted rare pediatric disease designation to LM-030, an investigational therapy licensed from Novartis and ready to enter into pivotal clinical trials for the ...

Ping An Good Doctor Joins Forces With Nearly 50 Hospitals in China to Build New "Internet Hospitals" Model

SHANGHAI, July 18, 2019 /PRNewswire/ -- The world leading online healthcare ecosystem platform, Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor", or the "Company"; stock code: 01833.HK), has announced that it had reached strategic cooperation with nearly 50 hospitals across China, including the Aviation General Hospital of China Medical University, ...

Eton Pharmaceuticals: Short-Term Setback, Proven Business Model

Acting Normal: US FDA's Unusual Interim Period Drags On

The messaging around the US FDA commissioner transition has emphasized continuity and business-as-usual. But this is still all pretty weird.   

Financial Visibility and Accelerated Development - Advicenne signs € 20 million financing agreement with European Investment Bank to support future development

Regulatory News: Advicenne (Paris:ADVIC) (BSE:ADVIC) (Euronext Paris Brussels: ADVIC FR0013296746), a specialty pharmaceutical company focused on the development and commercialization of therapeut...

Society for Immunotherapy of Cancer Publishes First Clinical Immunotherapy Treatment Guidelines for Squamous Cell Carcinoma of the Head and Neck

The Society for Immunotherapy of Cancer (SITC) has published the first clinical immunotherapy treatment guidelines for squamous cell carcinoma of the head and neck (HNSCC), providing oncologists and other advanced practice providers a clinical roadmap to treating this disease with immunotherapies approved in the United States. “The Society for Immunotherapy of Cancer consensus statement on immun...

The American Journal of Managed Care® Adds Innovation and Value Initiative to Its Strategic Alliance Partnership Program

The American Journal of Managed Care® (AJMC®), the leading multimedia peer-reviewed journal dedicated to issues in managed care, has added Innovation and Value Initiative (IVI) to its Strategic Alliance Partnership (SAP) program. “IVI is committed to improving value assessment in health care through collaboration of leaders in all different areas of the health care landscape,” said Michae...


Quick Search

News Quicklinks